SPP1 and metabolic dysfunction-associated steatotic liver disease: Serum SPP1 levels were measured in 179 patients with NAFLD and 123 HC patients and were significantly elevated in patients with NAFLD, and were independently associated with liver enzymes and portal inflammation (24).